Minimal Change Disease Associated With Durvalumab.
Toda MG, Fujii K, Kato A, Yoshifuji A, Komatsu M, Amino Y, Kitazono S, Hashiguchi A, Ryuzaki M.
Toda MG, et al. Among authors: kato a.
Kidney Int Rep. 2021 Sep 1;6(10):2733-2734. doi: 10.1016/j.ekir.2021.08.021. eCollection 2021 Oct.
Kidney Int Rep. 2021.
PMID: 34622115
Free PMC article.
No abstract available.